Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Part of Special Issue: The Therapeutic Potential of Novel and Emerging Anti-fibrotic Drugs The Anti-Fibrotic Potential of GLP-1 and GIP Receptor Agonists in Chronic Inflammatory Disorders: Mechanisms and Therapeutic Horizons Simon W
Think in visible signals: movement, grooming, appetite steadiness, and a body condition that looks comfortable. DVM Voice: Clinical Vignette of When Skin Changes Point Deeper Than the Surface Case provided by Sarah Calvin, DVM Maverick, a 4-year-old Siamese cat, was brought in for hair loss across his lower abdomen and red, flaky skin lesions that had progressed over the previous month
20 Post hoc analysis of the SUSTAIN trials comparing semaglutide with alternative GLP-1 agonists suggests superiority of semaglutide for weight loss and blood-glucose control, an effect that was independent of the presence of gastrointestinal adverse events
doi: 10.1177/1049909113494748 7
US$ 25.37
US$ 24.28
US$ 21.26
US$ 25.32
